multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
Published 1 year ago • 452 plays • Length 41:23Download video MP4
Download video MP3
Similar videos
-
1:02:05
adjuvant egfr-targeted therapy as a game changer in multimodal nsclc management
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
42:55
egfr-targeted therapy for early-stage nsclc: what thoracic surgeons need to know
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
1:11:16
immunotherapy as a game-changer in multimodal management of lung cancer
-
57:37
emerging role of egfr-targeted therapy in resectable lung cancer
-
1:03:31
elevating care in resectable stage i-iii nsclc
-
22:53
paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
1:02
novel perioperative strategies for non-small cell lung cancer